fbpx

Here's How It Works

Download the SurgiQuality app now!

  • surgi_connet_appstoreSurgiQuality
  • surgi_connet_playstoreSurgiQuality

Latest Articles

Hyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19

01/28/2022

A clinical trial has found that the combination of remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, is not more effective than remdesivir alone for treating adults hospitalized with the disease. The trial also found that the safety of this experimental treatment may vary depending on whether a person naturally generates SARS-CoV-2-neutralizing antibodies before receiving it. The results of the multinational Phase 3 trial were published today in the journal The Lancet.

More...

People's long-term pain after knee surgery is reduced, new treatment has shown

01/27/2022

With one in five people experiencing ongoing pain long after knee replacement surgery, new research, led by the University of Bristol and North Bristol NHS Trust (NBT) and published in The Lancet Rheumatology today, has shown a way to help reduce people's continuing pain that could also save the NHS time and money too.

More...

Infant deaths from RSV are much higher than previously known: study

01/27/2022

A new study found that nearly one in ten of all deceased infants under 6 months old were infected with Respiratory Syncytial Virus (RSV). Two-thirds of infant fatalities from RSV occurred in the community and would have been excluded from mortality estimates based on hospital data.

More...